Avanos Medical (AVNS) EV to CFO (2014 - 2026)

Avanos Medical has disclosed EV to CFO across 13 years of filings, most recently posting 47.83 for Q1 2026.

• In Q1 2026, EV to CFO fell 317.34% year-over-year to 47.83; the TTM figure through Mar 2026 stood at 16.03 (up 280.92% YoY), while the FY2025 annual figure was 5.78, down 6.7% from the prior year.
• EV to CFO came in at 47.83 for Q1 2026 at Avanos Medical, down from 15.32 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 822.81 in Q1 2022 to a low of 428.94 in Q2 2023.
• Average EV to CFO over 5 years is 28.7, with a median of 29.58 recorded in 2024.
• Year-over-year, EV to CFO soared 235.63% in 2022 and slumped 1086.17% in 2023.
• Over 5 years, EV to CFO stood at 33.57 in 2022, then surged by 122.34% to 74.64 in 2023, then slumped by 85.56% to 10.78 in 2024, then surged by 42.11% to 15.32 in 2025, then tumbled by 412.28% to 47.83 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 47.83 in Q1 2026, 15.32 in Q4 2025, and 33.29 in Q3 2025.